ED is a growing problem for men U30 and the more options available is only a good thing.
I believe we won’t be around this time next year with a sizeable offer from the likes of a Pfizer or BP. $1B acquisition is pocket change for a gamechanger like this.
- Forums
- ASX - By Stock
- LTP
- Life Science Review article
LTP
ltr pharma limited
Add to My Watchlist
4.48%
!
35.0¢

Life Science Review article, page-31
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
35.0¢ |
Change
0.015(4.48%) |
Mkt cap ! $39.18M |
Open | High | Low | Value | Volume |
34.0¢ | 37.5¢ | 34.0¢ | $358.4K | 1.002M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 10000 | 35.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
35.5¢ | 4295 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 10000 | 0.350 |
3 | 8998 | 0.345 |
5 | 40000 | 0.340 |
4 | 135669 | 0.335 |
7 | 128669 | 0.330 |
Price($) | Vol. | No. |
---|---|---|
0.355 | 4295 | 2 |
0.360 | 9662 | 4 |
0.365 | 27729 | 4 |
0.370 | 64660 | 2 |
0.375 | 19410 | 2 |
Last trade - 13.10pm 12/08/2025 (20 minute delay) ? |
Featured News
LTP (ASX) Chart |